Advertisement
AIZ vs ILMN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIZ is a Hold and ILMN is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AIZ’s FA Score shows that 1 FA rating(s) are green whileILMN’s FA Score has 0 green FA rating(s).
- AIZ’s FA Score: 1 green, 4 red.
- ILMN’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AIZ’s TA Score shows that 5 TA indicator(s) are bullish while ILMN’s TA Score has 4 bullish TA indicator(s).
- AIZ’s TA Score: 5 bullish, 4 bearish.
- ILMN’s TA Score: 4 bullish, 4 bearish.
Price Growth
AIZ (@Specialty Insurance) experienced а +1.40% price change this week, while ILMN (@Medical Specialties) price change was -13.39% for the same time period.
The average weekly price growth across all stocks in the @Specialty Insurance industry was -2.47%. For the same industry, the average monthly price growth was -2.73%, and the average quarterly price growth was -0.13%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -2.56%. For the same industry, the average monthly price growth was -2.26%, and the average quarterly price growth was -4.37%.
Reported Earning Dates
AIZ is expected to report earnings on Nov 04, 2025.
ILMN is expected to report earnings on Oct 30, 2025.
Industries' Descriptions
@Specialty Insurance (-2.47% weekly)Specialty insurance typically caters to niche-markets, and covers items that are special or unique and/or items that are not typically covered under other insurance policies. Restoration or purchase of a one-of-a-kind collector’s item, high-value home, recreational vehicles, sailboat or even jet skis, horses and farms, all-terrain vehicle, funerals, museums and fine art collections are some examples– one or more of which are covered by a specialty insurance provider. In some cases, a specialty insurance could also complement someone’s existing auto, home and umbrella policies. Markel Corp, for Fidelity National Financial, Inc., Assurant, Inc. and Athene Holding Ltd. are examples of specialty insurance providers.
@Medical Specialties (-2.56% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| AIZ | ILMN | AIZ / ILMN | |
| Capitalization | 9.78B | 21.1B | 46% |
| EBITDA | N/A | -608M | - |
| Gain YTD | -11.868 | -29.163 | 41% |
| P/E Ratio | 15.67 | 49.50 | 32% |
| Revenue | 11.1B | 4.5B | 246% |
| Total Cash | 3.73B | 1.05B | 354% |
| Total Debt | 2.08B | 2.26B | 92% |
AIZ | ILMN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 67 | 67 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 58 Fair valued | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 37 | 100 | |
SMR RATING 1..100 | 92 | 94 | |
PRICE GROWTH RATING 1..100 | 61 | 46 | |
P/E GROWTH RATING 1..100 | 29 | 92 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AIZ's Valuation (58) in the Specialty Insurance industry is in the same range as ILMN (78) in the Biotechnology industry. This means that AIZ’s stock grew similarly to ILMN’s over the last 12 months.
AIZ's Profit vs Risk Rating (37) in the Specialty Insurance industry is somewhat better than the same rating for ILMN (100) in the Biotechnology industry. This means that AIZ’s stock grew somewhat faster than ILMN’s over the last 12 months.
AIZ's SMR Rating (92) in the Specialty Insurance industry is in the same range as ILMN (94) in the Biotechnology industry. This means that AIZ’s stock grew similarly to ILMN’s over the last 12 months.
ILMN's Price Growth Rating (46) in the Biotechnology industry is in the same range as AIZ (61) in the Specialty Insurance industry. This means that ILMN’s stock grew similarly to AIZ’s over the last 12 months.
AIZ's P/E Growth Rating (29) in the Specialty Insurance industry is somewhat better than the same rating for ILMN (92) in the Biotechnology industry. This means that AIZ’s stock grew somewhat faster than ILMN’s over the last 12 months.
| AIZ | ILMN | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 75% | 2 days ago 65% |
| Stochastic ODDS (%) | 2 days ago 56% | 2 days ago 75% |
| Momentum ODDS (%) | N/A | 2 days ago 71% |
| MACD ODDS (%) | 2 days ago 61% | 2 days ago 75% |
| TrendWeek ODDS (%) | 2 days ago 58% | 2 days ago 78% |
| TrendMonth ODDS (%) | 2 days ago 49% | 2 days ago 72% |
| Advances ODDS (%) | 16 days ago 57% | 5 days ago 72% |
| Declines ODDS (%) | 9 days ago 47% | 3 days ago 81% |
| BollingerBands ODDS (%) | 2 days ago 81% | 2 days ago 64% |
| Aroon ODDS (%) | 2 days ago 61% | 2 days ago 75% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VGI | 7.88 | 0.01 | +0.13% |
| VIRTUS GLOBAL MULTI-SECTOR Income FUND | |||
| ARLU | 28.34 | N/A | N/A |
| AllianzIM U.S. Equity Buffer15 UncAprETF | |||
| FIRI | 18.94 | N/A | N/A |
| FIRE Funds Income Target ETF | |||
| DJAN | 40.58 | -0.34 | -0.82% |
| FT Vest US Equity Dp Bffr ETF Jan | |||
| TILT | 224.75 | -3.71 | -1.62% |
| FlexShares Mstar US Mkt Factors Tilt ETF | |||
AIZ and
Correlation & Price change
A.I.dvisor indicates that over the last year, AIZ has been closely correlated with AXS. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if AIZ jumps, then AXS could also see price increases.